2021
DOI: 10.1007/s00415-021-10561-2
|View full text |Cite
|
Sign up to set email alerts
|

Visual evoked potential latency predicts cognitive function in people with multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…There are 3 main components of the examination, namely, electroretinogram (ERG), electrooculogram (EOG), and visual evoked potential (VEP), all of which are objective and noninvasive [ 9 , 10 ]. It has proved to be of great value in the detection of declining visual function and is now widely used in the diagnosis, differentiation, prognosis, and pathogenesis of various ophthalmic disorders [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…There are 3 main components of the examination, namely, electroretinogram (ERG), electrooculogram (EOG), and visual evoked potential (VEP), all of which are objective and noninvasive [ 9 , 10 ]. It has proved to be of great value in the detection of declining visual function and is now widely used in the diagnosis, differentiation, prognosis, and pathogenesis of various ophthalmic disorders [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…This suggested that the prolongation of reaction time might be a result of an effort to reduce the rate of error. Previous studies also supported that SRTT results indicated longer reaction times in patients with MS and that this difference became further manifest with increased severity of disease (18)(19)(20)(21)(22). Previous studies on memory in patients with MS generally reported impaired memory (23)(24)(25)(26)(27)(28)(29).…”
Section: Discussionmentioning
confidence: 56%
“…In a recent review this computerized cognitive assessment battery was found to have adequate psychometric properties for the assessment of PwMS (Wojcik et al, 2019). NeuroTrax has been previously used in MS research (Covey et al, 2021;Golan et al, 2020Golan et al, , 2018Gudesblatt et al, 2018;Lapshin et al, 2012) and is sensitive to detect even mild cognitive impairment in patients (de Oliveira and Brucki, 2014;Dwolatzky et al, 2003).…”
Section: Neurotraxmentioning
confidence: 99%